Funding for this research was provided by:
National Eye Institute (R43 EY026821-01)
Received: 29 April 2017
Accepted: 16 November 2017
First Online: 25 November 2017
Ethics approval and consent to participate
: The clinical trial was approved by Chesepeake Independent Review Board, June 2016 and registered with ClinicalTrials.gov NCT02910362. All patients were treated according to the Declaration of Helsinki document on human research ethics, and underwent both verbal and written informed consent.
: Not applicable.
: There are no financial or associative conflicts of interest to disclose by the authors.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.